Abstract-Novel 1,4-benzodiazepine compounds were synthesized and evaluated for their ability to inhibit the proliferation of tumor cells. Some compounds revealed activities in the micromolar range and were more efficient than reference compound Ro 5-4864. Preliminary SAR helped to identify critical motifs for antiproliferative activity and led to the discovery of a compound selective of a melanoma cell-line, known for its resistance to chemotherapy.
Benzodiazepines are widespread compounds used for the treatment of mental disorders. A few years ago, some of these compounds showed antiproliferative properties against some tumor cell lines. This highlights them as potential anticancer agents. 1, 2 We are presently resorting to the 1,4-benzodiazepine scaffold, a suitable template for combinatorial chemistry 3 , to design small inhibitors of STAT3 dimerization. STAT3 (Signal Transducer and Activator of Transcription 3) plays a key role in cancer, by regulating as a dimer the expression of antiapoptotic or pro-survival genes. 4 Dimerization occurs upon phosphorylation on its Tyr705, through reciprocal interaction between the SH2 (Src Homology 2) domain of STAT3 and the pTyr residue. On the basis of preliminary molecular modelling based on the X-ray crystal structure of STAT3 5 , the N-1 position on the 1,4-benzodiazepine structure ( Figure  1 ) was used to substitute phosphate or phosphonate analogues, mimicking the role of pTyr in its SH2 domain interaction. The C-3 position was used to introduce a basic substituent to probe the effect of a possible ionic interaction with the SH2 domain.
The compounds were evaluated by an ELISA test for their ability to disrupt in vitro STAT3 dimerization but showed no significant activity. Nevertheless, they were further evaluated for their possible antiproliferative activities on two STAT3-dependent cell lines, NIH 3T3/v-Src cells 6 and melanoma cells A2058 7 , as well as on Hela cells, a cervical carcinoma tumor cell line, whose growth is not dependent on STAT3. 8 Here, we report the synthesis and biological evaluation of our derivatives. The synthesis of the diazepine core is described in Scheme 1. Peptidic coupling of 2-aminobenzophenone with suitably protected alanine or lysine could be achieved by the in situ formation of acyl-fluoride 9 compounds with the use of tetramethylfluoroformamidinium hexafluorophosphate (TFFH) to give 1 and 2 in 69-85% yields. Boc and Cbz protecting groups were completely removed respectively by treatment with 20% trifluoroacetic acid (TFA) in methylene chloride and by Pd-catalyzed hydrogenolytic cleavage. Cyclization to obtain the diazepine core was achieved using 5% of acetic acid in methylene chloride to give 3 and 4 in quantitative yield. The preparation of two brominated derivatives necessary for the N-alkylation of the core diazepine is described in Scheme 2. 4-hydroxybenzylalcohol was treated with dibenzylphosphite 10 to give dibenzylprotected phosphate derivative 5 in 70% yield. Transformation of the benzyl alcohol 5 to the bromide derivative 6 was achieved in 63% yield using triphenylphosphine and carbon tetrabromide. 11 Bromide 8 was obtained by Boc-protecting p-cresol followed by N-bromosuccinimide (NBS) bromination in 65% yield. The 4-(di-tertbutylphosphonomethyl)benzylbromide used to synthesize 10 and 13 was prepared as previously described. 12 Alkylation of diazepines 3 and 4 (Scheme 3) with benzyl bromide derivatives in the presence of the mild base cesium carbonate 13 afforded 9-13 in 80-90% yields. Final compounds 16, 17 and 20 were obtained in quantitative yield, by treatment with 50% TFA in methylene chloride for 3h. Under such conditions, compounds 9 and 12 gave monobenzyl-protected compounds 14 and 18, and the unprotected analogs 15 and 19 in about equal proportions. The lack of inhibitory effects of these benzodiazepines against STAT3 dimerization led us to investigate if alternatively, and in line with the findings reported in the litterature 14 , they could inhibit Src kinase activity. However, no inhibitory effect was found in the case of the present compounds.
Nevertheless, in cell assays, some of the benzodiazepine derivatives demonstrated efficient antiproliferative activities, inhibiting cell growth with IC 50 in the micromolar range. Cell growth inhibition was first evaluated on v-Src transformed mouse fibroblasts.
15
The cytotoxic activity of all the compounds was then tested against two human tumor cell lines, A2058 and HeLa cells, using a WST-1 colorimetric test. 16 Results are given in Table 1 . In addition, the benzodiazepine Ro 5-4864 (4'-chlorodiazepam), whose antiproliferative activity has already been demonstrated against some tumor cell lines
We therefore investigated if a hydroxyl group could be sufficient to retain activity. 4-hydroxylated compound 17 was accordingly synthesized and was found to be as efficient as the phosphate analogue 15. These data indicate that the presence of an oxygen atom seems critical for antiproliferative activity. Moreover, they suggest that it may be possible to optimize potency with other O-substituted compounds. On the other hand, the most potent compounds (14, 15 and 17) were also active on HeLa cells, indicating that they probably do not target the STAT3 pathway. [17] [18] [19] , was also evaluated as the reference compound.
These data indicate that whilst the unsubstituted benzodiazepine 3 is inactive towards any of the three cell types, some of our substituted benzodiazepines are more efficient than reference compound Ro 5-4864, on both human tumor cell lines. N-1 unsubstituted compound 3 showed no antiproliferative activity towards any of the three cell types, indicating that further substitutions are necessary for biological activity. For the C-3 methyl series (R 4 = CH 3 ), N-substitution with a p-phosphorylated benzyl moiety improved activity in each cell type with IC 50 in the micromolar range (15). Monobenzyl-protected phosphate derivative 14, initially synthesized to improve cell penetration, was less potent than the free phosphate analog 15 against the three cell types. Interestingly, phosphate replacement with phosphonate abrogated biological activity in each cell type. The higher pKa value of phosphonate derivative may be the cause for the loss of activity. 20 The presence of an oxygen atom at the p-position on the benzyl ring may also be important.
For the C-3 aminobutyl series (R 4 = (CH 2 ) 4 NH 2 ), the phosphonate derivative 20 was also inactive. These data confirmed the importance of a phenolic group or a p-phosphorylated benzyl moiety. Monobenzyl-protected phosphate derivative 18 could not be tested because of low solubility. Surprisingly, HAL author manuscript inserm-00168656, version 1 -4 -introduction of a basic alkyl chain in C-3 position led to a compound (19) rather selective of melanoma cells, with only weak potency on the two other cell types.
In the literature, other benzodiazepines, such as Ro 5-4864, have been shown to have antiproliferative activity, most of the time via an undefined or uncertain mechanism. [17] [18] [19] Whilst PBR (Peripheral Benzodiazepine Receptor) has been reported to be a possible target 18, 19 , benzodiazepine derivative Bz-423 has recently been found to induce antiproliferative activity independent of the PBR. 21 Thus, to our knowledge, the present work reports one of the first SAR studies, regarding the effects of substitution on both N-1 and C-3 position, on antiproliferative properties of 1,4-benzodiazepines. Although our compounds did not inhibit STAT3 dimerization in the Src-STAT3 pathway, they displayed interesting antiproliferative activities against different tumor cell lines. Benzodiazepines 14, 15 and 17 were even more efficient than reference compound Ro 5-4864 on both human tumor cell lines. Preliminary SAR helped us to identify critical motifs for activity and led to the discovery of a compound selective for a melanoma cell line, known for its resistance to chemotherapy. 22 In conclusion, these two series of benzodiazepines are promising leads for the development of anticancer agents. Further experiments will be done to identify their physiological target and improve the potency and the selectivity of both series of compounds.
